These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34181466)

  • 1. The Urinary Microbiome in Postmenopausal Women with Recurrent Urinary Tract Infections.
    Vaughan MH; Mao J; Karstens LA; Ma L; Amundsen CL; Schmader KE; Siddiqui NY
    J Urol; 2021 Nov; 206(5):1222-1231. PubMed ID: 34181466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the composition of the intestinal microbiota predict the development of urinary tract infections?
    den Heijer CD; Geerlings SE; Prins JM; Beerepoot MA; Stobberingh EE; Penders J
    Future Microbiol; 2016 Oct; 11():1395-1404. PubMed ID: 27785923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.
    Thomas-White K; Taege S; Limeira R; Brincat C; Joyce C; Hilt EE; Mac-Daniel L; Radek KA; Brubaker L; Mueller ER; Wolfe AJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):727.e1-727.e11. PubMed ID: 32791124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections.
    Anglim B; Phillips C; Shynlova O; Alarab M
    Int Urogynecol J; 2022 Aug; 33(8):2107-2117. PubMed ID: 34003309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Vaginal Estrogen on the Urobiome in Postmenopausal Women With Recurrent Urinary Tract Infection.
    Jung CE; Estaki M; Chopyk J; Taylor BC; Gonzalez A; McDonald D; Shin J; Ferrante K; Wasenda E; Lippmann Q; Knight R; Pride D; Lukacz ES
    Female Pelvic Med Reconstr Surg; 2022 Jan; 28(1):20-26. PubMed ID: 33978602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2012 May; 172(9):704-12. PubMed ID: 22782199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine and vaginal microbiota compositions of postmenopausal and premenopausal women differ regardless of recurrent urinary tract infection and renal transplant status.
    Hugenholtz F; van der Veer C; Terpstra ML; Borgdorff H; van Houdt R; Bruisten S; Geerlings SE; van de Wijgert JHHM
    Sci Rep; 2022 Feb; 12(1):2698. PubMed ID: 35177690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary microbiome community types associated with urinary incontinence severity in women.
    Carnes MU; Siddiqui NY; Karstens L; Gantz MG; Dinwiddie DL; Sung VW; Bradley M; Brubaker L; Ferrando CA; Mazloomdoost D; Richter HE; Rogers RG; Smith AL; Komesu YM;
    Am J Obstet Gynecol; 2024 Mar; 230(3):344.e1-344.e20. PubMed ID: 38937257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation.
    Mitchell CM; Ma N; Mitchell AJ; Wu MC; Valint DJ; Proll S; Reed SD; Guthrie KA; Lacroix AZ; Larson JC; Pepin R; Raftery D; Fredricks DN; Srinivasan S
    Am J Obstet Gynecol; 2021 Aug; 225(2):159.e1-159.e15. PubMed ID: 33675793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury.
    Fouts DE; Pieper R; Szpakowski S; Pohl H; Knoblach S; Suh MJ; Huang ST; Ljungberg I; Sprague BM; Lucas SK; Torralba M; Nelson KE; Groah SL
    J Transl Med; 2012 Aug; 10():174. PubMed ID: 22929533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The etiology and management of recurrent urinary tract infections in postmenopausal women.
    Jung C; Brubaker L
    Climacteric; 2019 Jun; 22(3):242-249. PubMed ID: 30624087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome.
    Neugent ML; Kumar A; Hulyalkar NV; Lutz KC; Nguyen VH; Fuentes JL; Zhang C; Nguyen A; Sharon BM; Kuprasertkul A; Arute AP; Ebrahimzadeh T; Natesan N; Xing C; Shulaev V; Li Q; Zimmern PE; Palmer KL; De Nisco NJ
    Cell Rep Med; 2022 Oct; 3(10):100753. PubMed ID: 36182683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Agents to Decrease New Episodes of Recurrent Lower Urinary Tract Infections in Postmenopausal Women. A Systematic Review.
    Dueñas-Garcia OF; Sullivan G; Hall CD; Flynn MK; OʼDell K
    Female Pelvic Med Reconstr Surg; 2016; 22(2):63-9. PubMed ID: 26825411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Clinical Trial of Standard versus Expanded Cultures to Diagnose Urinary Tract Infections in Women.
    Barnes HC; Wolff B; Abdul-Rahim O; Harrington A; Hilt EE; Price TK; Halverson T; Hochstedler BR; Pham T; Acevedo-Alvarez M; Joyce C; Fitzgerald CM; Schreckenberger PC; Brubaker L; Wolfe AJ; Mueller ER
    J Urol; 2021 Nov; 206(5):1212-1221. PubMed ID: 34184930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary microbiota of women with recurrent urinary tract infection: collection and culture methods.
    Hochstedler BR; Burnett L; Price TK; Jung C; Wolfe AJ; Brubaker L
    Int Urogynecol J; 2022 Mar; 33(3):563-570. PubMed ID: 33852041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence.
    Pearce MM; Hilt EE; Rosenfeld AB; Zilliox MJ; Thomas-White K; Fok C; Kliethermes S; Schreckenberger PC; Brubaker L; Gai X; Wolfe AJ
    mBio; 2014 Jul; 5(4):e01283-14. PubMed ID: 25006228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
    Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
    Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the relationship between vaginal and urinary microbiomes.
    Komesu YM; Dinwiddie DL; Richter HE; Lukacz ES; Sung VW; Siddiqui NY; Zyczynski HM; Ridgeway B; Rogers RG; Arya LA; Mazloomdoost D; Levy J; Carper B; Gantz MG;
    Am J Obstet Gynecol; 2020 Feb; 222(2):154.e1-154.e10. PubMed ID: 31421123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
    Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis.
    Alanee S; El-Zawahry A; Dynda D; McVary K; Karr M; Braundmeier-Fleming A
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):446-452. PubMed ID: 30664733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.